CN111728693A - System for treating arrhythmia by adopting pulsed electric field ablation technology - Google Patents
System for treating arrhythmia by adopting pulsed electric field ablation technology Download PDFInfo
- Publication number
- CN111728693A CN111728693A CN202010638621.8A CN202010638621A CN111728693A CN 111728693 A CN111728693 A CN 111728693A CN 202010638621 A CN202010638621 A CN 202010638621A CN 111728693 A CN111728693 A CN 111728693A
- Authority
- CN
- China
- Prior art keywords
- catheter
- ablation
- spline
- electric field
- annular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002679 ablation Methods 0.000 title claims abstract description 99
- 230000005684 electric field Effects 0.000 title claims abstract description 26
- 206010003119 arrhythmia Diseases 0.000 title claims abstract description 25
- 230000006793 arrhythmia Effects 0.000 title claims abstract description 22
- 238000005516 engineering process Methods 0.000 title claims abstract description 6
- 238000013507 mapping Methods 0.000 claims abstract description 6
- 230000000747 cardiac effect Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 8
- 238000009413 insulation Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 229920005570 flexible polymer Polymers 0.000 claims description 2
- 230000000661 pacemaking effect Effects 0.000 claims 3
- 239000012774 insulation material Substances 0.000 claims 1
- 210000003492 pulmonary vein Anatomy 0.000 abstract description 31
- 230000002427 irreversible effect Effects 0.000 abstract description 8
- 206010003658 Atrial Fibrillation Diseases 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 6
- 208000003734 Supraventricular Tachycardia Diseases 0.000 abstract description 4
- 230000001746 atrial effect Effects 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000003416 augmentation Effects 0.000 abstract description 3
- 230000036279 refractory period Effects 0.000 abstract description 2
- 238000009827 uniform distribution Methods 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 8
- 239000011810 insulating material Substances 0.000 description 7
- 238000002955 isolation Methods 0.000 description 7
- 229920002614 Polyether block amide Polymers 0.000 description 6
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 6
- 239000004642 Polyimide Substances 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 229920009441 perflouroethylene propylene Polymers 0.000 description 5
- 229920001721 polyimide Polymers 0.000 description 5
- 238000013153 catheter ablation Methods 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 238000007674 radiofrequency ablation Methods 0.000 description 3
- 208000006687 Esophageal Fistula Diseases 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 206010003662 Atrial flutter Diseases 0.000 description 1
- 229910001020 Au alloy Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000022306 Cerebral injury Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010065835 Oesophageal fistula Diseases 0.000 description 1
- 206010058522 Oesophageal injury Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 208000008376 Pre-Excitation Syndromes Diseases 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- 206010049171 Pulmonary vein stenosis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000000315 cryotherapy Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 239000003353 gold alloy Substances 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000005405 multipole Effects 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00357—Endocardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Electromagnetism (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
The invention provides a system for treating arrhythmia by adopting a pulsed electric field ablation technology, which comprises a voltage pulse system console, a pacing and ECG unit and an ablation catheter. The voltage pulse system console includes an electrical pulse generator, a controller, a human-machine interface, and a converter. The pacing and ECG unit comprises an ECG recorder, a pacing catheter, a cardiac stimulator and a mapping catheter, and pacing electric signals are synchronously transmitted to a voltage pulse system console. The ablation catheter is connected to a system console via a transducer, and based on the pacing signal, delivers a voltage pulse waveform during a refractory period of the cardiac cycle, delivering pulsed electric field energy to the ablated tissue via electrodes on the ablation catheter. The ablation catheter comprises a spline basket, the distal end of the spline basket is also provided with an annular catheter entering the pulmonary vein, and large-area irreversible injury in local, linear, annular or uniform distribution can be formed, so that the purpose of treating arrhythmia diseases such as atrial augmentation, supraventricular tachycardia and atrial fibrillation is achieved.
Description
Technical Field
The invention belongs to the field of medical instruments, relates to a system for treating arrhythmia by adopting a pulsed electric field ablation technology, and particularly relates to a multipolar irreversible electroporation ablation catheter for treating arrhythmia.
Background
Cardiac ablation has experienced a great deal of innovation and rapid development since its first implementation in 1969. Ablation was first used for the treatment of supraventricular tachycardia patients with accessory pathways and pre-excitation syndrome, and today ablation is commonly used for the treatment of atrial flutter, atrial fibrillation and ventricular arrhythmias.
The purpose of ablation is to destroy potentially arrhythmic tissue and form transmural and continuous permanent lesions. Percutaneous catheter ablation to achieve Pulmonary Vein (PV) isolation in atrial tissue using Radio Frequency Ablation (RFA) and cryotherapy has become a widely accepted procedure for treating Atrial Fibrillation (AF). Other forms of energy developed for catheter ablation include microwaves, high intensity focused ultrasound, low intensity collimated ultrasound, lasers, cryogenic energy, and heated saline.
Radio Frequency (RF) energy is currently the most commonly used energy source. RF creates lesions by resistively heating tissue and then conducting heat to deeper tissue. Although quite effective, it adversely affects not only the targeted tissue but also other surrounding tissue structures due to its inherent thermal conductivity properties. Especially during radiofrequency ablation, heat transfer can lead to esophageal damage (esophageal fistula formation), nerve septal damage, pulmonary vein stenosis, coagulum/thrombosis and subsequent risk of thromboembolism, all of which can lead to cerebral infarction or injury.
Cryoablation is another widely used mode of ablation, unlike radiofrequency. It ablates tissue by removing heat, causing the tissue to cool and freeze. However, like RF, cryoablation also causes complications including esophageal fistulas, stenosis of the Pulmonary Veins (PV), neuroparalysis and potentially pulmonary hemoptysis. Although both of these energy sources for ablation are effective to a large extent, it is desirable to attempt to improve ablation safety using alternative ablation energy sources.
Irreversible electroporation (IRE) is a rapidly developing, recognized and FDA approved solid tumor treatment, recently approved for the treatment of pancreatic cancer. Direct Current (DC) in the form of pulses is used to generate a local electric field that affects the permeability of the lipid bilayer of the cell membrane, thereby inducing the formation of nanoscale defects or pores, resulting in increased permeability of the cell. Depending on the electrical pulse parameter settings (e.g., pulse duration, voltage, frequency), this may be a reversible process, i.e., cells may survive through the reestablishment of cell membrane integrity and homeostasis, or irreversible electroporation leads to cell death.
IRE may be a promising approach for cardiac ablation, especially in comparison to RF, which can produce lesions without the consequence of thermal conduction, i.e. be able to preserve the surrounding tissue structure. In this Field, IRE is more commonly called Pulsed Field Ablation (PFA), and since PFA has potential advantages over the current Ablation methods, many preclinical animal experimental studies have been made, and recently, short-term clinical data of human body have been published for the first time. The annular pulmonary vein ablation catheter is used for delivering a pulse electric field to generate myocardial damage, the success rate of PFA acute isolation of pulmonary veins is 92.0%, and the method is proved to be a novel ablation method with potential, rapidness and safety. Reddy et al summarized two small-scale short-term human clinical studies with a PFA ablation parameter improvement with a 3-month pulmonary vein isolation success rate of 100% without stroke, nerve damage, PV stenosis and esophageal injury. The success rate of arrhythmia in 12 months is 87.4%.
This patent is to ablation system of PFA technical innovation design, can improve by a wide margin and melt efficiency and security, is applied to arrhythmia treatment field, expects to reach the purpose of diseases such as quick, safe, effectual treatment arrhythmia.
Disclosure of Invention
The invention aims to provide a system for treating arrhythmia by adopting a pulsed electric field ablation technology, which comprises a voltage pulse system console, a pacing and ECG unit and an ablation catheter.
The voltage pulse system console includes an electrical pulse generator, a controller, a human-machine interface, and a converter.
The pacing and ECG unit comprises an ECG recorder, a pacing catheter, a cardiac stimulator and a mapping catheter, and pacing electric signals are synchronously transmitted to a voltage pulse system console.
The ablation catheter comprises a distal section, a main body middle section and a proximal section control handle which are sequentially connected.
The ablation catheter is connected to a system console via a transducer, and based on the pacing signal, delivers a voltage pulse waveform during a refractory period of the cardiac cycle, delivering pulsed electric field energy to the ablated tissue via electrodes on the ablation catheter. During an ablation discharge, the transducer isolates the pacing and ECG units from the pulse system console.
The distal section of the ablation catheter includes at least one spline basket formed of flexible, extendable splines, each spline having at least one electrode thereon.
Preferably, the splined basket preferably has 2 to 4 electrodes per spline.
The spline basket is preferably 1 or 4-10 splines. In one embodiment, the splined basket includes 1 spline. In another embodiment, the splined basket preferably comprises 4 to 10 splines.
In one embodiment, the spline circular tube body is a circular tube made of flexible high polymer insulating materials, an insulated conducting wire in an insulated high polymer hose is connected with an electrode embedded on the surface of the spline, and the insulated conducting wire is connected to an electric socket of the control handle through the catheter body.
Preferably, the outer diameter of the spline circular tube is 0.2-3 mm, the inner diameter of the spline circular tube is 0.1-2.9 mm, and the length of the spline is 10-60 mm.
In one embodiment, the extendable flexible spline proximal end is connected to the catheter body intermediate section; the distal end of the spline is fixed on a guide rod with an inner cavity, the guide rod is directly connected to a rotary handle or a push rod of a control handle at the proximal section of the catheter, and can also be connected to the handle through a pull wire, and the spline at the distal section can be formed into a spline basket or the spline basket is folded into an extending state through the control handle.
When a plurality of splines are provided, in a state of opening to form a spline basket, the splines are uniformly distributed on a basket-shaped sphere of 360 degrees in three-dimensional space.
In one embodiment, each electrode on the spline is annular, the outer diameter of each annular electrode is 0.3-3 mm, and the length of each annular electrode is 1-20 mm; the electrodes are insulated and separated by elastic electric insulating high molecular materials, and the electric insulation is more than 500V.
In one embodiment, the voltage pulse system console can address each electrode on the spline; further, electrodes on adjacent splines are selected to carry out positive and negative paired discharge, and positive and negative paired discharge ablation can also be carried out on different electrodes on the same spline.
In one embodiment, the distal section of the ablation catheter further comprises an annular catheter connected to the distal end of the spline basket; the structure of the annular conduit is preferably an annular formed by one circular ring, a cylindrical or spiral conical formed by more than two circular rings; the annular conduit has at least one electrode thereon.
Preferably, the annular outer diameter of the annular conduit in the expanded state is 10-30 mm; the number of electrodes is 5-15; the length of the electrode is 1-4 mm.
Further, the voltage pulse system console can address each electrode of the annular catheter, so that the electrodes in the annular catheter are selected for ablation by discharging, and the voltage pulse system console can also be matched with the electrodes on the spline basket for ablation by discharging.
In one embodiment, two adjacent electrodes in the annular catheter are set as positive and negative electrodes, and pulse discharge ablation is completed sequentially or simultaneously.
The beneficial technical effects obtained by the invention are as follows:
1) the ablation catheter comprises a spline basket, the distal end of the spline basket is also provided with an annular catheter entering the pulmonary vein, except for the discharge ablation of the electrode on the spline basket at the opening of the pulmonary vein, the electrode on the annular catheter can be paired in the pulmonary vein for discharge ablation, and the electrode on the spline basket and the electrode on the annular catheter can also be paired for bipolar discharge ablation, so that the ablation range is increased from the conventional annular ablation of the pulmonary vein opening to the annular ablation in the pulmonary vein and the cylindrical ablation between the two rings, the ablation area is rapidly enlarged, and the purpose of effectively isolating the pulmonary vein for a longer period is achieved.
2) The electrodes in the control spline basket and the annular catheter are selected to perform discharge ablation, so that large-area irreversible damage in local, linear, annular or uniform distribution can be formed, and the purpose of treating arrhythmia diseases such as atrial augmentation, supraventricular tachycardia and atrial fibrillation is achieved.
3) This annular catheter can get into pulmonary vein through melting the wire guide chamber of pipe, and the pulmonary vein's of annular catheter location makes better fixing of spline basket at the pulmonary vein mouth, improves the better and tissue contact of electrode on it, improves the efficiency of melting of pulmonary vein mouth, and then forms complete pulmonary vein and keeps apart. In addition, the annular catheter can also detect the effect of pulmonary vein isolation in time.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this application, illustrate embodiment(s) of the invention and together with the description serve to explain the invention without limiting the invention. In the drawings:
FIG. 1 is a schematic diagram of a pulsed electric field ablation system according to the present invention;
FIG. 2 is a schematic view of the general construction of the pulsed electric field ablation catheter of the present invention;
FIG. 3 is a schematic structural view of one embodiment of a spline basket of the present invention;
FIG. 4 is a schematic structural view of a second embodiment of a splined basket of the present invention;
FIG. 5 is a schematic structural view of a third embodiment of a spline basket of the present invention;
FIG. 6 is a schematic structural view of a fourth embodiment of a spline basket of the present invention;
FIG. 7 is a schematic structural view of one embodiment of the annular duct of the present invention;
FIG. 8 is a schematic structural view of a second embodiment of the annular duct of the present invention;
FIG. 9 is a schematic structural view of a third embodiment of the annular duct of the present invention;
FIG. 10 is a schematic view of the overall configuration of a distal catheter in accordance with one embodiment of the present invention;
FIG. 11 is a schematic view of the extended configuration of the distal ring catheter of one embodiment of the present invention.
Detailed Description
Technical solutions of the present invention will be described in detail below by way of embodiments with reference to the accompanying drawings. It should be noted that the description of the embodiments is provided to help understanding of the present invention, but the present invention is not limited thereto.
As shown in FIG. 1, a system for treating cardiac arrhythmia using pulsed electric field ablation techniques generally includes a voltage pulse system console 110, a pacing and ECG unit 120, and an ablation catheter 130.
The voltage pulse system console 110 includes an electrical pulse generator 114, a controller 113 (containing a processor), a human-machine interface 111 with a display, and a converter 112.
The ablation catheter 130 is connected to the system console via the transducer 112, and the pulsed electric field is delivered to the ablated tissue via electrodes on the ablation catheter; during an ablation discharge, the transducer isolates the pacing and ECG units from the pulse system console.
A pacing and ECG unit 120 including an intracardiac stimulator 121, an ECG recorder 122, a mapping catheter 124, a pacing catheter 125, and a connector 123, the pacing electrical signals being delivered synchronously to the voltage pulse system console 110; based on the pacing signal, system console 110 issues an ablation pulse into the tissue within the refractory window. In embodiments thereof, the refractory window follows the ventricular pacing signal, or a short lag, and lasts no more than 130ms, with the entire ablation discharge being within the interval.
An ablation catheter 130 includes a distal section 131 (in the body), a body mid-section 132 and a proximal section 133 connected in series.
Fig. 2 is a schematic view showing the overall structure of the pulsed electric field ablation catheter of the present invention. The distal segment 131 includes, among other things, a treatment tip, such as a splined basket and/or an annular catheter.
The main body middle section 132 is a slender tube, and includes a hollow inner cavity, and a catheter, an electric wire, a guide wire and the like are disposed in the inner cavity.
The proximal body segment 133 contains a control handle 331. the handle 331 includes a component 332 for receiving a guidewire or other therapeutic device, and the handle 331 includes a connector 336 connected to the body of the handle. The handle 331 may include a pull assembly 335 for manipulating the head member of the distal segment 131, a lever or knob 334, and an actuator 333. The proximal end of the pull assembly 335 may be anchored to a member, such as a cam, in communication with the lever or knob 334 and responsive to the lever or knob 334. An actuating member 333 is movably coupled to the proximal portion of the catheter and/or handle 331 to manipulate and move the distal segment 131 treatment head member. The actuator 333 may comprise a sliding key, button, rotating lever, or other mechanical structure movably connected to a handle or catheter.
The catheter of the middle section 132 of the main body is a woven mesh tube with excellent torsion control performance, the inner cavity of the mesh tube is of a single-cavity or multi-cavity structure, and the insulating material of the inner cavity is TPU or Pebax, and can also be polyimide, FEP, ETFE or PTFE with smaller friction coefficient and better insulating performance; the middle mesh grid is woven by stainless steel, Nitinol and other alloy wires; the outer layer is made of biocompatible electric insulating materials such as TPU, Pebax, nylon and the like.
The middle section 132 of the ablation catheter is woven with a mesh tube, if the ablation catheter is of a single-cavity structure, a guide wire cavity is formed by TPU, PeBax, silicone rubber, polyimide, FEP, ETFE and PTFE tubes, and the far end of the guide wire cavity extends into the spline basket; the proximal end enters the handle, and forms a guidewire lumen with the cavity on the luer fitting through which the guidewire and the annular mapping catheter pass directly to the pulmonary vein.
The ablation catheter distal section 131 can also be a mesh-covered balloon, and electrodes embedded in the balloon surface complete the discharge ablation.
The distal section 131 of the ablation catheter can also have an annular multi-pole structure, the catheter is adapted to a pulmonary vein opening and has an outer diameter of 2-5 cm, the number of the electrodes is 4-16, two adjacent electrodes are arranged as an anode and a cathode, pulse discharge ablation is sequentially completed, and complete pulmonary vein isolation is formed.
The ablation catheter is connected to a system console via a transducer, and based on the pacing signal, the pulse generator is programmed to deliver to the electrodes high voltage pulses, either unidirectional pulses or bidirectional pulses, or other combinations, sufficient to cause irreversible electroporation of myocardial tissue cells within the refractory window. The method comprises the following steps of voltage ranging from 100 to 3500V, pulse width ranging from 10 to 1500 microseconds, pulse interval ranging from 10 to 2000 microseconds and pulse sequence ranging from 1 to 500 milliseconds, wherein each ablation part can be single-pulse-train ablation or multi-pulse-train ablation to form irreversible tissue electroporation denaturation.
As shown in FIGS. 3-6, in the head piece of the distal segment 131, the splined basket 50 preferably has 1 or 4-10 multiple flexibly extendable splines.
At least one electrode 52 is provided on each spline, and these electrodes 52 deliver high voltage pulses to the tissue, which can also be used for mapping. The splined basket comprises 2 to 14 flexibly extendable splines 51, preferably 4 to 10 splines 51; there are 1 to 6 conductive electrodes 52, preferably 2 to 4 electrodes 52 on each spline 51.
The spline basket comprises 1 or more splines 51 made of flexible high polymer insulating materials, an insulated wire in an insulated high polymer hose is connected with a plurality of electrodes 52 embedded on the surface of a round spline tube, and the insulated wire is connected to an electric socket of the control handle through a catheter main body. The spline main body circular tube is a tube made of flexible high polymer insulating materials, and comprises but is not limited to polyimide, FEP, TPU, Pebax, nylon and silica gel, an insulated wire in the insulated high polymer hose is connected with an electrode embedded on the surface of the spline, and the insulated wire is connected to an electric socket at the near end of the handle through the catheter main body.
Preferably, the outer diameter of the round tube of the spline 51 is 0.2-3 mm, the inner diameter is 0.1-2.9 mm, and the length of the round tube of the spline is 10-60 mm.
In one embodiment, the expandable flexible spline basket 50 is attached proximally to the catheter 210 in the midsection of the catheter body; the distal end of the spline is secured to a fastener 53 having an internal cavity. The fastener and guide rod 54 with lumen are connected by a pull wire to a knob or push rod of a proximal control handle by which the distal spline can be formed into a splined basket or retracted into an extended state.
As shown in fig. 3, in one embodiment, the spline basket 50 includes 8 splines 51. As shown in fig. 4, in one embodiment, the spline basket 50 includes 6 splines 51.
When a plurality of splines 51 are provided, in a state where the spline basket 50 is opened to form a basket shape, the splines are uniformly distributed on a basket-shaped sphere of 360 degrees in three-dimensional space.
As shown in fig. 5 and 6, in one embodiment, the splined basket 50 includes 1 splined circular tube 51 in the form of a large middle and two small spiral basket-like structure.
In one embodiment, each electrode 52 on the spline is annular, and the outer diameter of the annular electrode 52 is 0.3-3 mm, and the length is 1-20 mm; the electrodes 52 are insulated and separated by an elastic electric insulating polymer material, and the electric insulation is more than 500V.
In one embodiment, the voltage pulse system console can address each electrode 52 on the spline; further, the electrodes 52 on the adjacent splines are selected to perform positive and negative paired discharge, and positive and negative paired discharge ablation can also be performed on different electrodes 52 on the same spline.
As shown in fig. 3-6, a plurality of extendable flexible splines are attached proximally to the catheter 210 in the midsection of the catheter body; the distal end of each spline is secured to a fastener 53 having an internal cavity.
In one embodiment, the ablation catheter handle 331 has a slider bar, gear and pull wire configuration therein. The pull wire of one set of mechanism is connected with the spline basket 50, and the spline basket is formed by rotating or pushing and pulling on the handle 331, or the spline basket is collected by straightening the spline, so that preparation is made for repositioning or ablating other pulmonary veins. The pull wire of the other set of position control mechanism is connected to the proximal end of the spline basket, and the direction of the spline basket is controlled through a knob on the handle or a push button, so that the spline basket is perfectly attached to pulmonary vein orifices in different directions.
The fixing piece 53 is connected to a rotary handle or a push rod of the proximal handle through a pull wire, and the spline of the distal section is formed into a spline basket or is folded into a straight state through the handle; under the state of forming the spline basket by opening, all the splines are uniformly distributed on the basket-shaped sphere of 360 degrees in three-dimensional space.
Each electrode on the flexible spline is annular, the outer diameter of each annular electrode is 0.3-3 mm, and the length of each annular electrode is 1-20 mm; the electrode material is selected from platinum, platinum alloy, gold alloy, silver, stainless steel, nickel-titanium alloy and graphene; the electrodes are isolated by elastic electric insulating high molecular materials, and the electric insulation is more than 500V.
The voltage pulse system console 110 can address each electrode 52, select the electrodes 52 on adjacent splines to discharge in positive and negative pairs, or perform ablation in positive and negative pairs with different electrodes 52 on the splines, or other combinations of discharges.
The wire guide cavity in the center of the spline basket is made of insulating materials such as polyimide, PEEK, PTFE, FEP, ETFE, TPU and Pebax.
As shown in fig. 7-9, another configuration of the ablation catheter is: the distal section, in addition to the splined basket, has an annular conduit 60 attached to the distal end of the splined basket; the annular duct comprises an insulating circular tube 61. The outer wall of the annular duct 60 has a plurality of electrodes 62.
The circular tube 61 is a tube made of a flexible polymer insulating material, and includes but is not limited to polyimide, FEP, TPU, Pebax, nylon, and silica gel, an insulated wire in the insulated polymer hose is connected with an electrode embedded on the surface of the spline, and the insulated wire is connected to an electrical socket at the proximal end of the handle through the catheter main body.
As shown in fig. 7-9, the structure of the ring conduit preferably comprises a ring formed by one ring (fig. 7), a cylinder formed by more than two rings (fig. 8) or a spiral cone (fig. 9);
in one embodiment, the distal annular catheter 60 has an annular outer diameter of 10 to 30 mm, preferably 15 to 20 mm, in the expanded state; the number of the electrodes is 5 to 15, preferably 6 to 10. The length of the electrode is 1 to 4 mm, preferably 1.5 to 3 mm.
The loop catheter 60 can enter the pulmonary vein, effectively detect pulmonary vein isolation, and also can be used for electrospark ablation, and the loop catheter enters the pulmonary vein through a guide wire cavity of the ablation catheter.
In one embodiment, two adjacent electrodes 62 in the ring catheter 60 are configured as positive and negative electrodes, and the pulsed discharge ablation is performed sequentially or simultaneously to form a complete pulmonary vein isolation.
Further, the voltage pulse system console 110 may address each electrode 62 of the ring catheter, selecting the electrode 62 among them for spark ablation; and then the electrodes in the spline basket are selected for discharge ablation, or the electrodes and the electrodes on the spline basket are matched and combined for discharge ablation.
As shown in FIG. 10, the main body tube 61 of the annular catheter 60 extends from the lumen of the guide rod 54 of the splined basket 50 through the lumen of the fastener 53, wherein a plurality of extendable flexible splines 51 are attached proximally to the catheter 210 at the mid-section of the catheter body; the spline basket 50 has a distal end of each spline 51 secured to a fastener 53 having an internal lumen, and the guide rod 54 is retractable from the catheter 210 to control the expansion of the spline basket. The proximal control handle may control the extension of the looped catheter 60 over the guide wire.
In one embodiment, the voltage pulse system console 110 can address each electrode 62 of the annular catheter and each electrode 52 of the spline basket, select adjacent ones of which to discharge ablate the combination 62, thereby achieving stereoscopic cylindrical ablation.
The various combinations of different electrode arrangements and addressable electrodes at the far section of the catheter contacting the tissues form various high-voltage pulse electric field modes, for example, the electrode position and the electrode potential are set by adjusting, the electrodes on the annular catheter and the electrodes on the spline basket carry out multi-combination discharge, the discharge in a larger range is realized, and the discharge ablation area is more sufficient compared with that between two electrodes which are only adjacent. Thereby forming large area irreversible damage with local, linear, annular, conical or even distribution, and achieving the purpose of long-term treatment of different arrhythmia diseases such as atrial augmentation, supraventricular tachycardia, atrial fibrillation, etc.
FIG. 11 is a schematic view of the extended configuration of the distal ring catheter of one embodiment of the present invention. Wherein the guide wire 70 extends outside the ring catheter 60. The annular catheter 60 is extendable in a linear fashion to facilitate movement within the blood vessel; the guide wire is drawn out, and the annular catheter returns to a flexible annular shape to automatically adapt to the size of the pulmonary vein.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (12)
1. A system for treating arrhythmia by adopting a pulsed electric field ablation technology is characterized by comprising a voltage pulse system console, a pacing and ECG unit and an ablation catheter;
the voltage pulse system console comprises an electric pulse generator, a controller, a human-computer interface and a converter;
the pace-making and ECG unit comprises a cardiac stimulator, an ECG recorder, a pace-making catheter, a mapping catheter and a connector, and pace-making electric signals are synchronously transmitted to a voltage pulse system console;
the ablation catheter comprises a far section, a main body middle section and a near section control handle which are sequentially connected; the ablation catheter is connected to a system console through a converter, and a pulse electric field is transmitted to the ablation tissue through an electrode on the ablation catheter; during an ablation discharge, the transducer isolates the pacing and ECG units from the pulse system console.
2. The system for treating cardiac arrhythmia using pulsed electric field ablation technique of claim 1 wherein the distal section of the ablation catheter includes at least one spline basket of flexible stretchable splines with at least one electrode on each spline.
3. The system for treating arrhythmia using pulsed electric field ablation technique according to claim 2 wherein the splined basket is preferably 1 or 4-10 splines; there are preferably 2 to 4 electrodes on each spline.
4. The system for treating arrhythmia according to claim 3, wherein the splined tubular body is a tubular body made of flexible polymer insulation material, and the insulated wires in the insulated polymer flexible tube are connected with the electrodes embedded on the surface of the spline, and the insulated wires are connected to the electrical socket of the control handle through the catheter body.
5. The system for treating arrhythmia according to claim 4, wherein the spline tube has an outer diameter of 0.2-3 mm, an inner diameter of 0.1-2.9 mm, and a spline length of 10-60 mm.
6. The system for treating arrhythmia using pulsed electric field ablation technique of claim 4 wherein the extendable flexible spline proximal end is attached to the catheter body intermediate section; the distal end of the spline is fixed on a guide rod with an inner cavity, the guide rod is directly connected to a rotary handle or a push rod of a control handle at the proximal section of the catheter, and can also be connected to the handle through a pull wire, and the spline at the distal section can be formed into a spline basket or the spline basket is folded into an extending state through the control handle.
7. The system for treating arrhythmia using pulsed electric field ablation technique of claim 2 wherein each electrode on the spline is annular, the outer diameter of the annular electrode is 0.3-3 mm, and the length of the annular electrode is 1-20 mm; the electrodes are insulated and separated by elastic electric insulating high molecular materials, and the electric insulation is more than 500V.
8. The system for treating cardiac arrhythmia using pulsed electric field ablation technique of claim 3 where the voltage pulse system console can address each electrode on the spline; further, electrodes on adjacent splines are selected to carry out positive and negative paired discharge, and positive and negative paired discharge ablation can also be carried out on different electrodes on the same spline.
9. The system for treating arrhythmia using pulsed electric field ablation technique of claim 2 wherein the distal section of the ablation catheter further has a ring catheter attached to the distal end of the splined basket; the structure of the annular conduit is preferably an annular formed by one circular ring, a cylindrical or spiral conical formed by more than two circular rings; the annular conduit has at least one electrode thereon.
10. The system for treating arrhythmia using pulsed electric field ablation technique according to claim 9 wherein the annular catheter has an outer annular diameter of 10-30 mm in the extended state; the number of electrodes is 5-15; the length of the electrode is 1-4 mm.
11. The system for treating arrhythmia using pulsed electric field ablation technique of claim 9 where the voltage pulse system console addresses each electrode of the ring catheter to select which electrode to perform spark ablation or to perform a paired combination with electrodes on the spline basket to perform spark ablation.
12. The system for treating arrhythmia using pulsed electric field ablation technique according to claim 9, wherein two adjacent electrodes in the ring catheter are set as anode and cathode to complete the pulsed discharge ablation sequentially or simultaneously.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010638621.8A CN111728693A (en) | 2020-07-06 | 2020-07-06 | System for treating arrhythmia by adopting pulsed electric field ablation technology |
| PCT/CN2021/091680 WO2022007490A1 (en) | 2020-07-06 | 2021-04-30 | System for treating arrhythmias using pulsed electric field ablation technology |
| PCT/CN2021/091678 WO2022007489A1 (en) | 2020-07-06 | 2021-04-30 | Ablation system having bendable electrode |
| US17/653,045 US20220249159A1 (en) | 2020-07-06 | 2022-03-01 | Systems and Devices for Ablation with Bendable Electrodes |
| US17/653,283 US20220183750A1 (en) | 2020-07-06 | 2022-03-02 | Systems for Treating Arrhythmia by Pulsed Field Ablation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010638621.8A CN111728693A (en) | 2020-07-06 | 2020-07-06 | System for treating arrhythmia by adopting pulsed electric field ablation technology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111728693A true CN111728693A (en) | 2020-10-02 |
Family
ID=72653243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010638621.8A Pending CN111728693A (en) | 2020-07-06 | 2020-07-06 | System for treating arrhythmia by adopting pulsed electric field ablation technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111728693A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113243987A (en) * | 2021-04-30 | 2021-08-13 | 上海鑫律通生命科技有限公司 | Ablation catheter system adopting combined electrode |
| CN113545841A (en) * | 2021-07-12 | 2021-10-26 | 心航路医学科技(广州)有限公司 | Ablation catheter |
| CN113558745A (en) * | 2021-08-11 | 2021-10-29 | 昆明市延安医院 | Pulse ablation catheter for treating pulmonary hypertension |
| WO2022007490A1 (en) * | 2020-07-06 | 2022-01-13 | 上海鑫律通生命科技有限公司 | System for treating arrhythmias using pulsed electric field ablation technology |
| CN114711958A (en) * | 2022-03-16 | 2022-07-08 | 苏州艾科脉医疗技术有限公司 | Multipolar ablation device for pulsed electric field |
| EP4079244A1 (en) * | 2021-04-19 | 2022-10-26 | Biosense Webster (Israel) Ltd. | Ire ablation systems and protocols using a basket catheter |
| CN115363735A (en) * | 2022-08-03 | 2022-11-22 | 上海玮启医疗器械有限公司 | Three-dimensional spiral pulse ablation catheter |
| WO2023016482A1 (en) * | 2021-08-10 | 2023-02-16 | 苏州艾科脉医疗技术有限公司 | High-voltage generating circuit for catheter and ablation tool |
| CN116196081A (en) * | 2023-02-07 | 2023-06-02 | 上海玮启医疗器械有限公司 | Circuit switching system and method for pulse ablation catheter |
| US12048479B2 (en) | 2020-09-10 | 2024-07-30 | Biosense Webster (Israel) Ltd. | Surface mounted electrode catheter |
| US12076071B2 (en) | 2020-08-14 | 2024-09-03 | Kardium Inc. | Systems and methods for treating tissue with pulsed field ablation |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020177765A1 (en) * | 2001-05-24 | 2002-11-28 | Bowe Wade A. | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination |
| WO2008152674A1 (en) * | 2007-06-14 | 2008-12-18 | Massimo Grimaldi | Catheter for percutaneous transcatheter ablation of cardiac arrhythmias using bipolar radiofrequency |
| CN101856271A (en) * | 2009-04-13 | 2010-10-13 | 韦伯斯特生物官能公司 | Epicardial mapping and ablation catheter |
| CN103479347A (en) * | 2012-06-13 | 2014-01-01 | 韦伯斯特生物官能(以色列)有限公司 | Gated sampling of electrocardiogram signals during ablation waveform zero-crossing |
| CN103619274A (en) * | 2011-05-02 | 2014-03-05 | 美敦力 | Compliant sleeves coupled with wire structures for cryoablation |
| CN103750899A (en) * | 2014-01-21 | 2014-04-30 | 深圳市惠泰医疗器械有限公司 | Multi-electrode basket catheter and manufacture method thereof |
| US20180085160A1 (en) * | 2016-01-05 | 2018-03-29 | Iowa Approach, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| CN109350221A (en) * | 2018-09-14 | 2019-02-19 | 白龙腾 | Reducing screw multipole ablation catheter |
| CN110662483A (en) * | 2017-04-28 | 2020-01-07 | 法拉普尔赛股份有限公司 | Systems, devices, and methods for delivering pulsed electric field ablation energy to endocardial tissue |
| CN210784647U (en) * | 2019-08-02 | 2020-06-19 | 深圳北芯生命科技有限公司 | Cryoablation device with sensor array |
-
2020
- 2020-07-06 CN CN202010638621.8A patent/CN111728693A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020177765A1 (en) * | 2001-05-24 | 2002-11-28 | Bowe Wade A. | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination |
| WO2008152674A1 (en) * | 2007-06-14 | 2008-12-18 | Massimo Grimaldi | Catheter for percutaneous transcatheter ablation of cardiac arrhythmias using bipolar radiofrequency |
| CN101856271A (en) * | 2009-04-13 | 2010-10-13 | 韦伯斯特生物官能公司 | Epicardial mapping and ablation catheter |
| CN103619274A (en) * | 2011-05-02 | 2014-03-05 | 美敦力 | Compliant sleeves coupled with wire structures for cryoablation |
| CN103479347A (en) * | 2012-06-13 | 2014-01-01 | 韦伯斯特生物官能(以色列)有限公司 | Gated sampling of electrocardiogram signals during ablation waveform zero-crossing |
| CN103750899A (en) * | 2014-01-21 | 2014-04-30 | 深圳市惠泰医疗器械有限公司 | Multi-electrode basket catheter and manufacture method thereof |
| US20180085160A1 (en) * | 2016-01-05 | 2018-03-29 | Iowa Approach, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| CN110662483A (en) * | 2017-04-28 | 2020-01-07 | 法拉普尔赛股份有限公司 | Systems, devices, and methods for delivering pulsed electric field ablation energy to endocardial tissue |
| CN109350221A (en) * | 2018-09-14 | 2019-02-19 | 白龙腾 | Reducing screw multipole ablation catheter |
| CN210784647U (en) * | 2019-08-02 | 2020-06-19 | 深圳北芯生命科技有限公司 | Cryoablation device with sensor array |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022007490A1 (en) * | 2020-07-06 | 2022-01-13 | 上海鑫律通生命科技有限公司 | System for treating arrhythmias using pulsed electric field ablation technology |
| US12076071B2 (en) | 2020-08-14 | 2024-09-03 | Kardium Inc. | Systems and methods for treating tissue with pulsed field ablation |
| US12048479B2 (en) | 2020-09-10 | 2024-07-30 | Biosense Webster (Israel) Ltd. | Surface mounted electrode catheter |
| US12102382B2 (en) | 2020-09-10 | 2024-10-01 | Biosense Webster (Israel) Ltd. | Biased electrodes for improved tissue contact and current delivery |
| EP4079244A1 (en) * | 2021-04-19 | 2022-10-26 | Biosense Webster (Israel) Ltd. | Ire ablation systems and protocols using a basket catheter |
| CN113243987A (en) * | 2021-04-30 | 2021-08-13 | 上海鑫律通生命科技有限公司 | Ablation catheter system adopting combined electrode |
| CN113545841A (en) * | 2021-07-12 | 2021-10-26 | 心航路医学科技(广州)有限公司 | Ablation catheter |
| WO2023016482A1 (en) * | 2021-08-10 | 2023-02-16 | 苏州艾科脉医疗技术有限公司 | High-voltage generating circuit for catheter and ablation tool |
| CN113558745A (en) * | 2021-08-11 | 2021-10-29 | 昆明市延安医院 | Pulse ablation catheter for treating pulmonary hypertension |
| WO2023016277A1 (en) * | 2021-08-11 | 2023-02-16 | 昆明市延安医院 | Pulsed ablation catheter for treating pulmonary arterial hypertension |
| CN114711958A (en) * | 2022-03-16 | 2022-07-08 | 苏州艾科脉医疗技术有限公司 | Multipolar ablation device for pulsed electric field |
| CN115363735A (en) * | 2022-08-03 | 2022-11-22 | 上海玮启医疗器械有限公司 | Three-dimensional spiral pulse ablation catheter |
| CN115363735B (en) * | 2022-08-03 | 2024-01-02 | 上海玮启医疗器械有限公司 | Three-dimensional spiral pulse ablation catheter |
| CN116196081B (en) * | 2023-02-07 | 2024-02-23 | 上海玮启医疗器械有限公司 | Circuit switching system and method for pulse ablation catheter |
| CN116196081A (en) * | 2023-02-07 | 2023-06-02 | 上海玮启医疗器械有限公司 | Circuit switching system and method for pulse ablation catheter |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022007490A1 (en) | System for treating arrhythmias using pulsed electric field ablation technology | |
| CN111728693A (en) | System for treating arrhythmia by adopting pulsed electric field ablation technology | |
| US20230329784A1 (en) | Intracardiac tools and methods for delivery of electroporation therapies | |
| CN111772783A (en) | Ablation system with bendable electrodes | |
| US10285755B2 (en) | Mesh-overlayed ablation and mapping device | |
| US7993333B2 (en) | Ablation catheters | |
| CN111388085A (en) | Cardiac pulse multipolar ablation catheter | |
| US20050010095A1 (en) | Multi-purpose catheter apparatus and method of use | |
| US20220249159A1 (en) | Systems and Devices for Ablation with Bendable Electrodes | |
| CN114469327B (en) | Ablation catheter and ablation treatment method thereof | |
| CA2570207A1 (en) | Ablation catheters and methods for their use | |
| CN114641245A (en) | Ablation assembly for treating a target region of tissue in an organ | |
| CN113243987A (en) | Ablation catheter system adopting combined electrode | |
| CN213851011U (en) | Ablation catheter with bendable electrodes | |
| CN213963615U (en) | Ablation catheter for arrhythmia treatment | |
| CN216124545U (en) | Ablation catheter adopting combined electrode | |
| CN219048803U (en) | Multi-balloon ablation system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20210326 Address after: 201318 room 505, block B, building 1, 800 Qingdai Road, Pudong New Area, Shanghai Applicant after: Shanghai xinlutong Life Technology Co.,Ltd. Address before: 036002 No.12, 9 / F, C building, Pingshuo singleton apartment, Shuocheng District, Shuozhou City, Shanxi Province Applicant before: Bai Longteng |